[go: up one dir, main page]

NO20080068L - Topisk unguale formuleringer - Google Patents

Topisk unguale formuleringer

Info

Publication number
NO20080068L
NO20080068L NO20080068A NO20080068A NO20080068L NO 20080068 L NO20080068 L NO 20080068L NO 20080068 A NO20080068 A NO 20080068A NO 20080068 A NO20080068 A NO 20080068A NO 20080068 L NO20080068 L NO 20080068L
Authority
NO
Norway
Prior art keywords
ungual
topical
formulations
nail
permeability
Prior art date
Application number
NO20080068A
Other languages
English (en)
Inventor
Robert Turner
Marc Barry Brown
Stuart Allen Jones
Original Assignee
Medpharm Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medpharm Ltd filed Critical Medpharm Ltd
Publication of NO20080068L publication Critical patent/NO20080068L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/40—Peroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Påføring av et reduksjonsmiddel fulgt av et oksidasjonsmiddel på en negl gir en vesentlig økning av neglens permeabilitet, hvorved passasje av medikamenter gjennom neglen tillates.
NO20080068A 2005-06-06 2008-01-04 Topisk unguale formuleringer NO20080068L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0511499.6A GB0511499D0 (en) 2005-06-06 2005-06-06 Topical ungual formulations
PCT/GB2006/002064 WO2006131721A2 (en) 2005-06-06 2006-06-06 Topical ungual formulations

Publications (1)

Publication Number Publication Date
NO20080068L true NO20080068L (no) 2008-03-05

Family

ID=34835209

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20080068A NO20080068L (no) 2005-06-06 2008-01-04 Topisk unguale formuleringer

Country Status (16)

Country Link
US (1) US20080207537A1 (no)
EP (1) EP1888029A2 (no)
JP (1) JP2008542349A (no)
KR (1) KR20080027765A (no)
CN (1) CN101203209A (no)
AU (1) AU2006256593A1 (no)
BR (1) BRPI0611115A2 (no)
CA (1) CA2610605A1 (no)
GB (1) GB0511499D0 (no)
IL (1) IL187893A0 (no)
MX (1) MX2007015424A (no)
NO (1) NO20080068L (no)
NZ (1) NZ563844A (no)
RU (1) RU2408361C2 (no)
WO (1) WO2006131721A2 (no)
ZA (1) ZA200710541B (no)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009048841A1 (en) * 2007-10-09 2009-04-16 Humco Holding Group, Inc. Antifungal treatment of nails
US9320921B2 (en) * 2008-12-22 2016-04-26 Karen C. Swenholt Nail fungus treatment and composition
EP2544659A2 (en) * 2009-12-23 2013-01-16 Nuvo Research Inc. Highly permeating terbinafine formulation for treating onychomycosis
BR112012023421B1 (pt) 2010-03-17 2021-09-14 Novaliq Gmbh Composição farmacêutica para tratamento de aumento de pressão intraocular
EP2444063A1 (en) 2010-10-20 2012-04-25 Novaliq GmbH Liquid pharmaceutical compositions for the delivery of active ingredients
EP2462921A1 (en) 2010-11-11 2012-06-13 Novaliq GmbH Liquid pharmaceutical compositions for the treatment of a posterior eye disease
JP5883886B2 (ja) * 2011-02-11 2016-03-15 モーベリ・ファルマ・エイビイ 抗真菌組成物
US9408867B2 (en) * 2011-05-11 2016-08-09 Veloce Biopharma, Llc Antifungal compositions for the treatment of skin and nails
EP3311802B1 (en) * 2011-05-25 2023-11-01 Dermaliq Therapeutics, Inc. Topical pharmaceutical composition based on semifluorinated alkanes
EP2714008B1 (en) * 2011-05-25 2016-12-14 Novaliq GmbH Pharmaceutical composition for administration to nails
CN104066442B (zh) 2012-01-23 2018-05-18 诺瓦利克有限责任公司 基于半氟化烷烃的稳定蛋白质组合物
EP4342537A3 (en) 2012-09-12 2024-07-03 Novaliq GmbH Semifluorinated alkane compositions
EP3100722B1 (en) 2012-09-12 2024-03-20 Novaliq GmbH Semifluorinated alkanes for use in solubilizing meibum
AU2014295052B2 (en) 2013-07-23 2018-08-30 Novaliq Gmbh Stabilized antibody compositions
ITUB20153759A1 (it) * 2015-09-21 2017-03-21 Federica Livieri Composizione antifungina ad uso topico per il trattamento dell'onicomicosi e relativo metodo
EP3356313B1 (en) 2015-09-30 2020-05-06 Novaliq GmbH 2-perfluorohexyl octane for ophthalmic administration
DE202016008738U1 (de) 2015-09-30 2019-04-09 Novaliq Gmbh Semifluorierte Verbindungen und ihre Zusammensetzungen
JP2019520357A (ja) 2016-06-23 2019-07-18 ノバリック ゲーエムベーハー 局所投与方法
PL3515420T3 (pl) 2016-09-22 2024-04-08 Novaliq Gmbh Kompozycje farmaceutyczne do zastosowania w terapii zapalenia brzegów powiek
CA3036306C (en) 2016-09-23 2024-05-14 Novaliq Gmbh Ophthalmic compositions comprising ciclosporin
EP3399962B1 (en) 2016-12-23 2020-06-10 Novaliq GmbH Ophthalmic composition for treatment of dry eye disease
CA3058097C (en) 2017-04-21 2024-01-02 Novaliq Gmbh Iodine compositions
US11278503B2 (en) 2017-05-12 2022-03-22 Novaliq Gmbh Pharmaceutical compositions comprising semifluorinated alkanes for the treatment of contact lense-related conditions
MX2020003534A (es) 2017-09-27 2020-07-29 Novaliq Gmbh Composiciones oftalmicas que comprenden latanoprost para usarse en el tratamiento de las enfermedades oculares.
CN119909046A (zh) 2017-10-04 2025-05-02 诺瓦利克有限责任公司 包含f6h8的眼用组合物
US11576893B2 (en) 2018-03-02 2023-02-14 Novaliq Gmbh Pharmaceutical compositions comprising nebivolol
RU2688658C1 (ru) * 2018-04-10 2019-05-22 Федеральное государственное бюджетное научное учреждение "Научно-исследовательский институт по изысканию новых антибиотиков имени Г.Ф. Гаузе" Противогрибковый полусинтетический полиеновый антибиотик, его водорастворимые соли и фармацевтические композиции на их основе
CN112153970A (zh) 2018-04-27 2020-12-29 诺瓦利克有限责任公司 用于治疗青光眼的包含他氟前列素的眼用组合物
CA3111870C (en) 2018-09-27 2022-04-12 Novaliq Gmbh Topical sunscreen formulation
US12029757B2 (en) 2018-09-27 2024-07-09 Dermaliq Therapeutics, Inc. Lipid barrier repair
CN112823020A (zh) 2018-10-12 2021-05-18 诺瓦利克有限责任公司 用于治疗干眼病的眼用组合物
EP3923907B1 (en) 2019-02-13 2024-09-25 Novaliq GmbH Compositions and methods for the treatment of ocular neovascularization
KR20210118571A (ko) * 2020-03-23 2021-10-01 제이씨코리아 주식회사 감압 점착제 조성물, 이를 포함하는 점착제, 상기 점착제를 포함하는 인조네일 및 네일용 스티커

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL95393A0 (en) * 1989-08-18 1991-06-30 John Morris Co Odor-masked and stabilized compositions for treating keratinous tissue,skin conditions,and promoting wound healing
IL97012A0 (en) * 1990-01-30 1992-03-29 Gist Brocades Nv Topical preparations for treating human nails
DE4337945A1 (de) * 1993-11-06 1995-05-11 Labtec Gmbh Pflaster zur Behandlung von Nagelmykosen
US5696164A (en) * 1994-12-22 1997-12-09 Johnson & Johnson Consumer Products, Inc. Antifungal treatment of nails
FR2767686B1 (fr) * 1997-09-01 2004-12-17 Oreal Composition pour la teinture d'oxydation des fibres keratiniques comprenant du 2-chloro 6-methyl 3-aminophenol et deux bases d'oxydation, et procede de teinture
US6231840B1 (en) * 1998-02-13 2001-05-15 Carol J. Buck Compositions and methods for the topical treatment of nail fungi conditions
WO1999049895A2 (en) * 1998-03-31 1999-10-07 Johnson And Johnson Consumer Companies, Inc. Method for increasing the permeability of horny human tissue
US20030007939A1 (en) * 1998-07-31 2003-01-09 Howard Murad Pharmaceutical compositions and methods for managing dermatological conditions
RU2186565C2 (ru) * 2000-03-13 2002-08-10 Большаков Сергей Борисович Способ лечения грибковых инфекций ногтей (онихомикозов)
US6281239B1 (en) * 2000-04-12 2001-08-28 Bradley Pharmeaceuticals, Inc. Method of treating onychomycosis
US6664292B2 (en) * 2001-06-04 2003-12-16 Mark H. Bogart Methods for the treatment of nail fungus and other microbial and mycotic conditions and compositions useful therefor
US6846837B2 (en) * 2002-06-21 2005-01-25 Howard I. Maibach Topical administration of basic antifungal compositions to treat fungal infections of the nails

Also Published As

Publication number Publication date
MX2007015424A (es) 2008-04-17
RU2007148974A (ru) 2009-07-20
EP1888029A2 (en) 2008-02-20
NZ563844A (en) 2011-01-28
US20080207537A1 (en) 2008-08-28
GB0511499D0 (en) 2005-07-13
KR20080027765A (ko) 2008-03-28
CA2610605A1 (en) 2006-12-14
JP2008542349A (ja) 2008-11-27
BRPI0611115A2 (pt) 2010-08-10
IL187893A0 (en) 2008-03-20
CN101203209A (zh) 2008-06-18
WO2006131721A3 (en) 2007-09-07
WO2006131721A2 (en) 2006-12-14
AU2006256593A1 (en) 2006-12-14
ZA200710541B (en) 2009-05-27
RU2408361C2 (ru) 2011-01-10

Similar Documents

Publication Publication Date Title
NO20080068L (no) Topisk unguale formuleringer
NO20083630L (no) Nye pyridinderivater
NL300936I2 (nl) Semaglutide
BRPI0806531A2 (pt) Composto, composição farmacêutica, agente terapêutico, e, uso do composto.
CL2009000393A1 (es) Composición farmaceutica que comprende a) un agente farmaceutico activable, b) un agente activo plasmonico; util para el tratamiento de trastornos de proliferación celular.
DE602007010664D1 (de) P53 aktivierende benzoylharnstoff- und benzoylthioharnstoff-verbindungen
NO20091395L (no) Nye tiofenderivater
ATE448777T1 (de) Mittel für die transdermale verabreichung von nikotin
MY158428A (en) Topical composition for the treatment of actinic keratosis
CL2008001656A1 (es) Anticuerpo anti-c3b; composicion farmaceutica que lo comprende, y su uso para prevenir o tratar un trastorno asociado con el complemento; kit que lo contiene.
EA201070689A1 (ru) Композиция для личного ухода
EA201170703A1 (ru) Производные адамантилбензамида
NO20090305L (no) Cyklosporin formuleringer
TR200504892A1 (tr) Belirti göstermeyen tüberküloz tedavisi
NO20082298L (no) Kaliumkanalinhibitorer
DE602007014036D1 (de) 12-aryl-prostaglandin-analoga
MX2009012767A (es) Metodos de tratamiento de infecciones fungicas.
BRPI0716643A2 (pt) amidas terapêuticas e compostos relacionados
BRPI0911772A2 (pt) composto, composição farmacêutica, e, uso do composto.
BRPI0513149A (pt) uso de 2-tio-3,5-diciano-4-fenil-6-aminopiridinas substituìdas no tratamento de náuseas e vÈmito
MA32321B1 (fr) Pregn-4-en-21, 17 carbolactones substitués sur le noyau c, et préparations pharmaceutiques contenant ces derniers
DE502006005053D1 (de) Spritzbare akustikmassen
TR200902923T2 (tr) Megestrol maddenin farmasötik olarak kararlı bir süspansiyonu.
UY28917A1 (es) Derivados de tetrahidroisoquinolilsulfonamidas composiciones farmaceuticas y su uso terapeutico
ITMI20040954A1 (it) Derivati del 3,6-diazabiciclo 3.1.i.eptano ad attivita' analgesica

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application